The GLP is committed to full transparency. Download and review our 2019 Annual Report

Video: Targeting glioblastoma and other deadly cancers with nanoparticles, chemotherapy

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Nanoparticles are capable of carrying chemotherapy to areas of the body afflicted by cancer. However, what if these nanoparticles were specifically targeted to treat only cancer cells and not healthy cells? Not only would treatment be far more effective, but these patients would be able to enjoy their lives due to treatment side effects being lessened. For the past three years undergraduate student, Stephen Frederico has been researching one of the deadliest forms of brain cancer called a glioblastoma. 

A College of Charleston student and current researcher at the Medical University of South Carolina, Stephen Frederico has dedicated himself to researching brain tumors, specifically the Glioblastoma Multiforme (GBM) tumor, a deadly tumor that took the life of a dear friend. A former baseball player with his sight on the major leagues, Stephen finds more fulfillment analyzing nanoparticles since retiring his glove. 

Can we treat cancer without side effects? With the use of nanoparticles, this college student and researcher supports chemotherapy treatments that still allow patients to live a full, optimistic life.

Read full, original post: Cancer Treatment Using Nanoparticles – Is It Possible?

Related article:  Family DNA disease connection: How my breast cancer diagnosis saved my father from pancreatic cancer
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend